Nakamura, S., Yonekura, S., Shimosato, T., & Takaya, T. (2021). Myogenetic Oligodeoxynucleotide (myoDN) Recovers the Differentiation of Skeletal Muscle Myoblasts Deteriorated by Diabetes Mellitus. Front Physiol.
Citação norma ChicagoNakamura, Shunichi, Shinichi Yonekura, Takeshi Shimosato, and Tomohide Takaya. "Myogenetic Oligodeoxynucleotide (myoDN) Recovers the Differentiation of Skeletal Muscle Myoblasts Deteriorated By Diabetes Mellitus." Front Physiol 2021.
Citação norma MLANakamura, Shunichi, Shinichi Yonekura, Takeshi Shimosato, and Tomohide Takaya. "Myogenetic Oligodeoxynucleotide (myoDN) Recovers the Differentiation of Skeletal Muscle Myoblasts Deteriorated By Diabetes Mellitus." Front Physiol 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.